NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Life Insurance Corporation of India (LIC) and Penny Stocks: A Tale of Two Markets

The recent performance of Life Insurance Corporation of India (LIC) highlights a stark contrast between the investment strategies employed by the insurer and those of retail investors in the penny stock market.

LIC has been actively investing in penny stocks, with a significant portion of its portfolio allocated to these high-risk, high-reward securities. Despite the risks, LIC has shown a willingness to take on substantial positions in these companies, often with significant returns.

In contrast, retail investors in the penny stock market often face significant challenges in navigating the complex regulatory environment and lack of transparency surrounding these securities. The lack of access to reliable information and the high risks associated with penny stocks can make it difficult for individual investors to make informed decisions.

Read also: Kumar Mangalam Birla to Address Concluding Function of RSS Training Camp

As of June 2022, LIC held a substantial stake in Innovent Biologics, a Chinese biotech company, and Fincare Small Finance Bank, an Indian non-banking financial company. The insurer's investment in these companies has yielded significant returns, with Innovent Biologics seeing a 400% increase in its stock price over the past year.

The disparity between LIC's investment approach and that of retail investors in the penny stock market serves as a reminder of the importance of understanding the risks and rewards associated with these securities. While LIC has the resources and expertise to navigate the complexities of the penny stock market, individual investors must exercise caution and conduct thorough research before making any investment decisions.

Key Figures:

  • June 2022: Date of LIC's investment in Innovent Biologics and Fincare Small Finance Bank
  • 400%: Increase in Innovent Biologics' stock price over the past year
  • Life Insurance Corporation of India (LIC): Indian state-owned life insurance company
  • Innovent Biologics: Chinese biotech company
  • Fincare Small Finance Bank: Indian non-banking financial company

Read also: The Cost of Healthcare: Why Predictability in Medical Inflation is Crucial for Health Insurance

Investor Takeaway

Investors should be cautious of the potential risks associated with penny stocks.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.